Close

InspireMD (NSPR) Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Peru

March 27, 2018 7:04 AM EDT Send to a Friend
InspireMD, Inc. (NYSE: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login